Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
ENTITY
Merus NV (MRUS US)
Watchlist
7
Analysis
Health Care
•
Netherlands
Merus N.V. operates as a clinical-stage immuno-oncology company. The Company focuses on developing bispecific antibody therapeutics. Merus develops and manufactures therapeutics to treat and cure cancer patients.
more
Watchlist
Filings
Presentations
Events
Earnings/Op Data
New
Refresh
Exchange Announcement •
12 Nov 2025 21:00
DEFM14A | Definitive proxy statement relating to merger or acquisition
Attachment
Exchange Announcement •
01 Nov 2025 04:00
Quarterly Report (Form 10-Q | Period ending 2025-09-30)
Attachment
Exchange Announcement •
04 Oct 2025 04:14
SC14D9C | Written communication by the subject company relating to a third party tender offer
Attachment
Exchange Announcement •
30 Sep 2025 05:08
SC14D9C | Written communication by the subject company relating to a third party tender offer
Attachment
Exchange Announcement •
29 Sep 2025 20:34
SC14D9C | Written communication by the subject company relating to a third party tender offer
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7
x